Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pimpinelli

Showing results (531-540 of 542) with videos related to

Pageof 55
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerElise A Olsen, Sean Whittaker, Youn H Kim, et al.
The British Journal of Dermatology|August 12, 2025
EORTC/USCLC/ISCL consensus recommendations for management and treatment of cutaneous lymphoproliferative disordersRein Willemze, Chalid Assaf, Martine Bagot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2020
Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive NomogramAndrea Maurichi, Rosalba Miceli, Hanna Eriksson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2020
Reply to E. HindiéAndrea Maurichi, Rosalba Miceli, Hanna Eriksson, et al.
Dermatology (Basel, Switzerland)|February 10, 2015
Differences in clinicopathological features and distribution of risk factors in Italian melanoma patientsP Fava, C Astrua, A Chiarugi, et al.
Blood|July 15, 2025
A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk StratificationJulia J Scarisbrick, Pietro Quaglino, Sean J Whittaker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International ConsortiumP Quaglino, M Maule, H M Prince, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2018
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International ConsortiumP Quaglino, M Maule, H M Prince, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week resultsBianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian studyB M Piraccini, F Pampaloni, S Cedirian, et al.
Pageof 55

Showing results (531-540 of 542) with videos related to

Sort By:
Pageof 55
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerElise A Olsen, Sean Whittaker, Youn H Kim, et al.
The British Journal of Dermatology|August 12, 2025
EORTC/USCLC/ISCL consensus recommendations for management and treatment of cutaneous lymphoproliferative disordersRein Willemze, Chalid Assaf, Martine Bagot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2020
Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive NomogramAndrea Maurichi, Rosalba Miceli, Hanna Eriksson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2020
Reply to E. HindiéAndrea Maurichi, Rosalba Miceli, Hanna Eriksson, et al.
Dermatology (Basel, Switzerland)|February 10, 2015
Differences in clinicopathological features and distribution of risk factors in Italian melanoma patientsP Fava, C Astrua, A Chiarugi, et al.
Blood|July 15, 2025
A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk StratificationJulia J Scarisbrick, Pietro Quaglino, Sean J Whittaker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International ConsortiumP Quaglino, M Maule, H M Prince, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2018
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International ConsortiumP Quaglino, M Maule, H M Prince, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week resultsBianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian studyB M Piraccini, F Pampaloni, S Cedirian, et al.
Pageof 55